Invokana 300 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FVFK4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,537
Award facts
- Contract value 100% obligated
- $11,537.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Invokana 300 mg tablets (90-count) with a ceiling value of $11,537.36. This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, represents a non-competitive, non-set-aside award and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Invokana is a diabetes medication commonly used within military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999.99 million and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen demonstrates significant capability in fulfilling federal medical procurement requirements through its established track record of competitively awarded contracts with the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FVFK4?
SPE2DB25FVFK4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FVFK4 worth?
The government has obligated $11,537 on SPE2DB25FVFK4.
Is contract SPE2DB25FVFK4 an order under another contract?
Yes. SPE2DB25FVFK4 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVFK4 competed?
The extent of competition for SPE2DB25FVFK4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award